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mLETTER TO THE EDITOR
Epidemiology  of  opportunistic  diseases  in  AIDS
patients  from  Pereira  municipality,  Colombia,
2010—2011
Morbidity and  mortality  related  to  acquired
immunodeﬁciency  syndrome  (AIDS)-deﬁning  oppor-
tunistic diseases  (ODs)  have  been  signiﬁcantly
reduced since  the  introduction  of  highly  active
anti-retroviral therapy  (HAART).  However,  they
still represented  a  signiﬁcant  epidemiological  bur-
den among  patients  with  AIDS  in  some  developing
countries [1,2].  Even  more,  there  is  few  recent
data, particularly  population-based,  about  the
prevalence  and  factors  associated  to  ODs  in  AIDS
patients  of  some  countries  of  South  America,  with
limited  access  to  HAART,  such  as  Colombia  [3,4].
Surveillance  studies  on  it  should  be  frequently
done. According  to  the  World  Health  Organization,
this country  is  in  the  list  of  nations  with  40—59%  of
eligible  people  receiving  HAART  at  the  end  of  2011
[4].
For  these  reasons  we  assessed  the  prevalence  of
ODs in  the  population  of  AIDS  patients  living  and
attended  in  the  municipality  of  Pereira,  the  capital
area of  Risaralda  department,  in  western  Colombia,
during 2010—2011.  This  population  is  included  in
the HIV  control  program  of  Pereira  municipality.
Pereira (459.667  pop.  for  2011)  is  one  of  the  munic-
ipalities  with  highest  incidence  of  HIV/AIDS  in  the
country, 34.6  cases/100,000  pop.  for  2011,  with  a
signiﬁcant increase  in  the  last  6  years  (2006—2011)
[5].
Patients  were  diagnosed  based  on  epidemi-
ological, clinical  and  serological  conﬁrmation
(ELISA HIV-1  and  HIV-2  tests  and  Western-
blot, with  voluntary  counseling  and  testing).
Data was  collected  through  the  Epidemiolog-
ical Surveillance  System  (SIVIGILA),  HIV/AIDS
trimester program  reports  and  through  HIV/AIDS
treatment cohort  reports.  Opportunistic  dis-
eases were  clinically,  microbiologically  and
pathologically diagnosed.  Collected  data  was
compiled  in  Excel  and  then  analyzed  with  SPSS
v.17.0®.
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http://dx.doi.org/10.1016/j.jiph.2013.07.003Between  January  2010  and  December  2011,
 total  305  cases  were  reported,  146  in  2010
31.94 cases/100,000  pop.)  and  159  in  2011
34.59 cases/100,000  pop).  These  corresponded
6.9% to  males  and  33.1%  to  females.  The  mean  age
as 35.5  years-old  (±13.8,  ±SD)  (37.25  years-old
or males  and  32.08  for  females,  p =  0.002).
From the  total  of  patients  for  the  study  period,
6 (24.9%)  presented  ≥1  OD  (95%CI  19.9—29.9%).
mong those  with  ODs,  72.4%  presented  only  1
f them,  18.4%  two  and  9.2%  three  or  more
Ds. Hospitalization  rate  was  signiﬁcantly  higher
mong  those  with  ODs  (64.5%)  compared  to  those
ree of  ODs  (27.9%)  (OR  = 4.68;  95%CI  2.69—8.12).
hose patients  with  age  ≥35  years-old  had  higher
revalence of ODs  (30.5%  vs.  20.1%  among  those
ounger)  (OR  =  1.74;  95%CI  1.03—2.94).  Lack  of
ocial security  (SS)  was  also  a  factor  inﬂuencing
igher prevalence  of  ODs,  among  those  without  SS
his was  36.7%,  compared  to  22.0%  among  those
ith SS  (OR  =  2.05;  95%CI  1.12—3.75).
In  the  patients  with  ODs  (n  =  76),  the  most
requent were  the  infections  due  to  atypi-
al mycobacteria  (23.7%),  followed  by  recurrent
neumonia (18.5%),  pulmonary  tuberculosis  (TB)
17.3%), esophageal  candidiasis  (14.4%),  emaci-
tion syndrome  (10.4%)  and  non-TB  meningitis
10.4%), among  others  (Fig.  1).  Some  of  the  ODs
ere signiﬁcantly  more  frequent  among  those
lder than  35  years-old.  Esophageal  candidiasis
OR =  5.56;  95%CI  1.18—2.63),  emaciation  syn-
rome (OR  =  8.55;  95%CI  1.04—71.43),  pulmonary
andidiasis (OR  =  1.05;  95%CI  1.01—1.08)  and  extra-
ulmonary  TB  (OR  = 1.03;  95%CI  1.01—1.06).
Case fatality  rate  (CFR)  was  signiﬁcantly  higher
mong  those  with  ODs  (18.7%)  compared  to  those
ree of  ODs  (3.5%)  (OR  =  6.3;  95%CI  2.54—15.81).
mong the  ODs,  there  were  some  more  associated
ith a higher  CFR.  Recurrent  pneumonia  due  to
almonella  (OR  =  28.1;  95%CI  2.44—323.34),  Pneu-
ocystis  jirovecii  pneumoniae  (OR  = 14.68;  95%CI
.77—77.72),  esophageal  candidiasis  (OR  =  8.69;
5%CI 2.33—32.49),  meningitis  (OR  =  8.75;  95%CI
.94—30.39) and  pulmonary  candidiasis  (OR  =  6.93;
 Sciences. Published by Elsevier Ltd. All rights reserved.
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Fig.  1  Types  of  opportunistic  diseases  among  AIDS  patients  of  Pereira,  Risaralda,  Colombia,  2010—2011.
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C5%CI  1.19—40.13).  At  multivariate  analyses,  with
 binary  logistic  regression  model,  only  meningi-
is was  signiﬁcantly  associated  (ORadjusted =  7.738;
5%CI 1.368—43.777).
Although  the  limitations  of  this  study,  presented
nformation shown  a  considerable  proportion  of
IDS patients  still  presenting  ODs  in  the  munici-
ality (almost  1  out  of  4),  with  high  proportion  of
hem dying  due  to  ODs  (almost  1  out  of  5).  With
his and  a  previous  report  [5], awareness  about
Ds prevalence  and  relevance  on  AIDS  patients
t the  municipality  of  Pereira  has  been  raised.
eading to  increase  education  activities  (includ-
ng workshops  for  healthcare  professionals)  and  to
ncrease surveillance  of  ODs  in  AIDS  patients.  For
ear 2011  Colombia  was  classiﬁed  by  the  PNUD
s a  country  of  high  human  development  (Human
evelopment Index,  HDI  =  0.717)  [6],  however  this
Ds prevalence  is  comparable  and  even  higher
han the  reported  by  countries  with  lowest  HDI,
uch as  Congo  (estimated  prevalence  of  ODs  for
007: 4—5%,  with  an  HDI  =  0.511  for  the  same
ear) [6,7].  For  TB,  Pereira  AIDS  patients  preva-
ence is  twice  than  those  reported  in  other  recent
tudies (2006)  in  Africa,  7.2%  in  Dar-es-Salaam,
s
1
tanzania  (a  country  with  a  HDI  = 0.401  for  2006)
6,8]. This  is  explained  in  part  due  to  a  high
revalence of  TB  in  general  population  in  Pereira
65.85 cases/100,000  pop.  in  2010)  [9].
HAART has  led  to  a substantial  increase  in
he survival  of people  living  with  AIDS,  despite
eterogeneities  among  individuals  from  different
ocioeconomic strata  [10], but  it  is  still  necessary
o warrant  its  universal  access  for  every  eligi-
le HIV/AIDS  patient  according  to  the  national
herapy guidelines  [11,12]. In  this  way  the  Colom-
ian  clinical  practice  guidelines  of  HIV/AIDS,
learly serves  as  the  evidence-based  document
o be  followed  in  the  diagnosis  and  manage-
ent of  HIV/AIDS,  including  opportunistic  diseases
nd special  conditions  [12].  More  prospective
tudies in  the  region  are  needed  to  know  the
revalence of  ODs  at  other  country  levels  and
ven more  primary  prevention  should  be  rise
n order  to  decrease  the  high  incidence  and
revalence of  HIV/AIDS  in  Pereira  and  Risaralda,
olombia and  deﬁnitively  the  coverage  of  HAART
hould be  signiﬁcantly  increase  up  to  ﬁnally  reach
00% of  HIV/AIDS  eligible  patients  in  the  coun-
ry.
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